Should we use Extracorporeal Photopheresis more often? Evidence from Graft-Versus-Host Disease Patients Monitored with Treg as a Biomarker

Sérgio Machado Lopes1 Department of Cellular Therapy, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal;2 Faculty of Medicine, University of Porto, Porto, 4200-319, PortugalCorrespondence[email protected]

https://orcid.org/0000-0002-4002-1071

Susana Roncon1 Department of Cellular Therapy, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal

Ana Catarina Pinho1 Department of Cellular Therapy, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal

Filipa Bordalo1 Department of Cellular Therapy, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal

Luís Antunes3 Department of Bone Marrow Transplant, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal

https://orcid.org/0000-0002-3098-0711

Fernando Campilho4 Department of Epidemiology, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal

António Campos4 Department of Epidemiology, Instituto Português de Oncologia do Porto, 4200-072Porto, Portugal

Altamiro Costa-Pereira5 Center for Health Technology & Services Research (CINTESIS), Department of Community Medicine, Information & Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, 4200-319Porto, Portugal

show all

Should we use Extracorporeal Photopheresis more often? Evidence from Graft-Versus-Host Disease Patients Monitored with Treg as a Biomarker

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Should we use Extracorporeal Photopheresis more often? Evidence from Graft-Versus-Host Disease Patients Monitored with Treg as a Biomarker

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date